A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

NCT07035093 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

586

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Chronic Low Back Pain (CLBP)

Interventions

DRUG: Retatrutide
DRUG: Placebo

Sponsor

Eli Lilly and Company